A series of 6 cases of optic neuropathy developing after systemic bevacizumab treatment for glioblastoma was reported [7], and this effect may have been due to the loss of VEGF's known neuroprotective effects with subsequent neuronal degeneration [14]. Here, VEGFA is linked to optic nerve disorder.